Mandate

Vinge advises consortium led by Advent International on acquisition of Hoist Group Holding Intressenter AB (publ)

Vinge together with Weil, Gotshal & Manges LLP is advising a consortium led by Advent International in connection with its acquisition of Hoist Group Holding Intressenter AB (publ) (the ”Hoist Group”).

Hoist Group provides technology solutions to hotels, enabling them to manage coherent end-to-end digital journeys for their guests. Hoist Group optimizes guest services by correlating and analyzing the data that comes from its innovative Property Management & Booking Software, Managed IP Networks, Internet and TV Content as well as from many other digital touchpoints. Headquartered in Stockholm with 20 offices across EMEA, Hoist Group has nearly 500 dedicated staff serving over 8,000 unique hotels.

The sale is subject to standard regulatory approval, among other things, and is expected to be completed in the second half of 2021. In France, the agreement is subject to completion of French works council consultations.

The Vinge team advising Advent International includes partners Daniel Rosvall, Henrik Borna and Anna Edström, counsel Emelie Svensäter Jerntorp and associates Carl Sander and Viktor Lennartsson. Counsel Fredrik Christiansson advises on financing matters

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025